LAURIE KEATING - 05 Aug 2021 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
EVP, Chief Legal Officer
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Laurie Keating
Issuer symbol
ALNY
Transactions as of
05 Aug 2021
Transactions value $
-$1,000,000
Form type
4
Filing time
09 Aug 2021, 16:09:55 UTC
Previous filing
04 Aug 2021
Next filing
19 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $700,570 +7,876 +153% $88.95 13,008 05 Aug 2021 Direct F1
transaction ALNY Common Stock Options Exercise $188,929 +2,124 +16% $88.95 15,132 05 Aug 2021 Direct F1
transaction ALNY Common Stock Sale -$1,889,500 -10,000 -66% $188.95 5,132 05 Aug 2021 Direct F1
holding ALNY Common Stock 434 05 Aug 2021 by Managed Account F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Performance Stock Option 2015 (right to buy) Options Exercise $0 -2,124 -15% $0 11,876 05 Aug 2021 Common Stock 2,124 $88.95 Direct F1
transaction ALNY Stock Option (right to buy) Options Exercise $0 -7,876 -88% $0 1,124 05 Aug 2021 Common Stock 7,876 $88.95 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.
F2 Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
F3 The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.